Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Total 13F shares
-
35,157,531
-
Share change
-
-4,713,826
-
Total reported value
-
$85,076,325
-
Put/Call ratio
-
119%
-
Price per share
-
$2.42
-
Number of holders
-
80
-
Value change
-
-$17,346,324
-
Number of buys
-
31
-
Number of sells
-
79
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q2 2022
As of 30 Jun 2022,
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,157,531 shares.
The largest 10 holders included
Redmile Group, LLC, Frazier Life Sciences Management, L.P., Versant Venture Management, LLC, VANGUARD GROUP INC, Palo Alto Investors LP, BlackRock Inc., Deep Track Capital, LP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and Assenagon Asset Management S.A..
This page lists
81
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.